Quinvaxem

Manufacturer Novartis Vaccines
Distributor Biogenetech
Contents Per 0.5 mL dose Purified diphtheria toxoid not <7.5 Lf (not <30 IU), purified tetanus toxoid not <3.25 Lf (not <60 IU), inactivated Bordetella pertussis not <15 OU (not less than 4 IU), purified HBsAg 10 mcg, Hib oligosaccharide 10 mcg conjugated to approx 25 mcg of CRM 197
Indications Active primary & booster immunisation of infants & toddlers for protection against diphtheria, tetanus, pertussis, hepatitis B & invasive illness caused by Hib.
Click to view Quinvaxem detailed prescribing infomation
Dosage Infant (1st yr of life) Primary vaccination 3 doses of 0.5 mL each, at least 1 mth apart, starting as early as 6 wk of age. Toddler (13-24 mth after birth) Reinforcing vaccination 1 booster dose of 0.5 mL. Administer IM in the anterolateral thigh or alternatively in the deltoid region in childn 13-24 mth after birth.
Click to view Quinvaxem detailed prescribing infomation
Overdosage View Quinvaxem overdosage for action to be taken in the event of an overdose.
Contraindications Hypersensitivity. Encephalopathy of unknown aetiology after a previous vaccination w/ pertussis vaccine.
Click to view Quinvaxem detailed prescribing infomation
Special Precautions Postpone vaccination in case of acute febrile illness. Careful consideration should be taken before administration of pertussis-containing vaccine if any of the following is observed: Temp 40°C, collapse or shock, persistent crying lasting >3 hr w/in 48 hr after vaccination; convulsions w/ or w/o fever w/in 3 days after vaccination. Avoid inj into a blood vessel. Thrombocytopenia or bleeding disorder.
Click to view Quinvaxem detailed prescribing infomation
Adverse Drug Reactions Inj site reactions, crying, diarrhoea, vomiting, fever, feeding disorders, sleepiness, irritability.
View ADR Monitoring Form
Drug Interactions Immunosuppressants, corticosteroids.
Caution For Usage For caution against possible variation of physical aspect of medicine… click to view Quinvaxem detailed prescribing infomation
Storage View Quinvaxem storage conditions for details to ensure optimal shelf-life.
Description View Quinvaxem description for details of the chemical structure and excipients (inactive components).
Mechanism of Action View Quinvaxem mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class Vaccines, Antisera & Immunologicals
ATC Classification J07CA11 – diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B ; Belongs to the class of combined bacterial and viral vaccines.
Thai FDA Category S
Form Photo Packing/Price
Quinvaxem vaccine Quinvaxem
(vial) 0.5 mL x 1′s
Quinvaxem

Quinvaxem vaccine

Novartis Vaccines
Thai FDA Category : S
Form : Vial
Contents : vaccine, tetanus, vaccine, Haemophilus b, vaccine, pertussis, vaccine, diphtheria, vaccine, hepatitis B
MIMS Class : Vaccines, Antisera & Immunologicals
Shape : Undefined

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>